Literature DB >> 1702007

Demonstration of the heterogeneity of epitopes of the platelet-specific alloantigen, Baka.

H Take1, Y Tomiyama, Y Shibata, T Furubayashi, S Honda, H Mizutani, T Nishiura, T Tsubakio, Y Kurata, T Yonezawa.   

Abstract

It is well known that the platelet-specific alloantigen, Baka is carried on glycoprotein (GP) IIb, but little is known about the biochemical characteristics of its epitopes. To clarify the characteristics of the epitopes, we examined the interaction of four anti-Baka sera (Yam, Lin, Kl and MO) with their epitopes, either with or without modifications by sodium dodecyl sulphate (SDS) and/or neuraminidase. By immunoprecipitation, all four antisera bound to the intact GP IIb/IIIa complex from a Baka-positive subject. In contrast, immunoblotting demonstrated that Yam, Lin and Kl bound to SDS-denatured GP IIb, while MO did not. When blotted GP IIb was treated with neuraminidase, Yam and Lin did not bind to desialylated GP IIb, while Kl still did. When the purified GP IIb/IIIa complex or washed platelets were treated first with neuraminidase followed by immunoblotting, the molecular weight of GP IIb decreased from 145 kD to 138 kD; Yam did not bind to desialylated GP IIb, but Kl did. Furthermore, to eliminate the effect of SDS, we examined the interaction of Yam and Lin with neuraminidase-treated platelets using flow cytometry. The results were the same as those obtained using immunoblotting. Our results thus demonstrate that the expression of the Baka epitopes is not uniform and that sialic acid contributes to the expression of some actual allogenic epitopes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702007     DOI: 10.1111/j.1365-2141.1990.tb06374.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  HNA-3a-specific antibodies recognize choline transporter-like protein-2 peptides containing arginine, but not glutamine at Position 154.

Authors:  Brian R Curtis; Mia J Sullivan; M Trudy Holyst; Aniko Szabo; Daniel W Bougie; Richard H Aster
Journal:  Transfusion       Date:  2011-04-22       Impact factor: 3.157

Review 2.  ABO Blood Group as a Model for Platelet Glycan Modification in Arterial Thrombosis.

Authors:  Ming Zhong; Hanrui Zhang; John P Reilly; Jason D Chrisitie; Mayumi Ishihara; Tadahiro Kumagai; Parastoo Azadi; Muredach P Reilly
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-04       Impact factor: 8.311

3.  Bioengineered iPSC-derived megakaryocytes for the detection of platelet-specific patient alloantibodies.

Authors:  Nanyan Zhang; Sentot Santoso; Richard H Aster; Brian R Curtis; Peter J Newman
Journal:  Blood       Date:  2019-11-28       Impact factor: 22.113

4.  Full-length recombinant choline transporter-like protein 2 containing arginine 154 reconstitutes the epitope recognized by HNA-3a antibodies.

Authors:  Adam J Kanack; Julie A Peterson; Mia J Sullivan; Daniel W Bougie; Brian R Curtis; Richard H Aster
Journal:  Transfusion       Date:  2011-10-27       Impact factor: 3.157

5.  Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopenia.

Authors:  Julie A Peterson; Stephanie M Balthazor; Brian R Curtis; Janice G McFarland; Richard H Aster
Journal:  Transfusion       Date:  2005-09       Impact factor: 3.157

6.  The human platelet alloantigens Br(a) and Brb are associated with a single amino acid polymorphism on glycoprotein Ia (integrin subunit alpha 2).

Authors:  S Santoso; R Kalb; M Walka; V Kiefel; C Mueller-Eckhardt; P J Newman
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.